193 related articles for article (PubMed ID: 33524535)
1. Development and optimisation of simulated salivary fluid for biorelevant oral cavity dissolution.
Ali J; Bong Lee J; Gittings S; Iachelini A; Bennett J; Cram A; Garnett M; Roberts CJ; Gershkovich P
Eur J Pharm Biopharm; 2021 Mar; 160():125-133. PubMed ID: 33524535
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of human saliva as a platform for oral dissolution medium development.
Gittings S; Turnbull N; Henry B; Roberts CJ; Gershkovich P
Eur J Pharm Biopharm; 2015 Apr; 91():16-24. PubMed ID: 25603197
[TBL] [Abstract][Full Text] [Related]
3. Application of biorelevant saliva-based dissolution for optimisation of orally disintegrating formulations of felodipine.
Ali J; Zgair A; Hameed GS; Garnett MC; Roberts CJ; Burley JC; Gershkovich P
Int J Pharm; 2019 Jan; 555():228-236. PubMed ID: 30465852
[TBL] [Abstract][Full Text] [Related]
4. Is rat a good model for assessment of particulate-based taste-masked formulations?
Ali J; Chiang M; Lee JB; Voronin GO; Bennett J; Cram A; Kagan L; Garnett MC; Roberts CJ; Gershkovich P
Eur J Pharm Biopharm; 2020 Jan; 146():1-9. PubMed ID: 31726218
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Dissolution Model Can Predict the in Vivo Taste Masking Performance of Coated Multiparticulates.
Keeley A; Teo M; Ali Z; Frost J; Ghimire M; Rajabi-Siahboomi A; Orlu M; Tuleu C
Mol Pharm; 2019 May; 16(5):2095-2105. PubMed ID: 30900905
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of a biorelevant medium simulating porcine gastrointestinal fluids.
Henze LJ; Koehl NJ; Jansen R; Holm R; Vertzoni M; Whitfield PD; Griffin BT
Eur J Pharm Biopharm; 2020 Sep; 154():116-126. PubMed ID: 32580049
[TBL] [Abstract][Full Text] [Related]
7. Critical view on drug dissolution in artificial saliva: A possible use of in-line e-tongue measurements.
Khaydukova M; Kirsanov D; Pein-Hackelbusch M; Immohr LI; Gilemkhanova V; Legin A
Eur J Pharm Sci; 2017 Mar; 99():266-271. PubMed ID: 28042103
[TBL] [Abstract][Full Text] [Related]
8. Multiparticulate system combining taste masking and immediate release properties for the aversive compound praziquantel.
Münster M; Schoch C; Schmidt C; Breitkreutz J
Eur J Pharm Sci; 2017 Nov; 109():446-454. PubMed ID: 28887230
[TBL] [Abstract][Full Text] [Related]
9. A new biorelevant dissolution method for orodispersible films.
Krampe R; Sieber D; Pein-Hackelbusch M; Breitkreutz J
Eur J Pharm Biopharm; 2016 Jan; 98():20-5. PubMed ID: 26515261
[TBL] [Abstract][Full Text] [Related]
10. Human saliva and model saliva at bulk to adsorbed phases - similarities and differences.
Sarkar A; Xu F; Lee S
Adv Colloid Interface Sci; 2019 Nov; 273():102034. PubMed ID: 31518820
[TBL] [Abstract][Full Text] [Related]
11. Development of an ex vivo retention model simulating bioadhesion in the oral cavity using human saliva and physiologically relevant irrigation media.
Madsen KD; Sander C; Baldursdottir S; Pedersen AM; Jacobsen J
Int J Pharm; 2013 May; 448(2):373-81. PubMed ID: 23538096
[TBL] [Abstract][Full Text] [Related]
12. Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.
Arndt M; Chokshi H; Tang K; Parrott NJ; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2013 Aug; 84(3):633-41. PubMed ID: 23434923
[TBL] [Abstract][Full Text] [Related]
13. Dissolution methodology for taste masked oral dosage forms.
Gittings S; Turnbull N; Roberts CJ; Gershkovich P
J Control Release; 2014 Jan; 173():32-42. PubMed ID: 24184344
[TBL] [Abstract][Full Text] [Related]
14. Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution Vessel.
Salehi N; Al-Gousous J; Mudie DM; Amidon GL; Ziff RM; Amidon GE
Mol Pharm; 2020 Oct; 17(10):3870-3884. PubMed ID: 32886520
[TBL] [Abstract][Full Text] [Related]
15. Design of biorelevant test setups for the prediction of diclofenac in vivo features after oral administration.
Guhmann M; Thommes M; Gerber F; Pöllinger N; Klein S; Breitkreutz J; Weitschies W
Pharm Res; 2013 Jun; 30(6):1483-501. PubMed ID: 23543303
[TBL] [Abstract][Full Text] [Related]
16. Validation of Dissolution Testing with Biorelevant Media: An OrBiTo Study.
Mann J; Dressman J; Rosenblatt K; Ashworth L; Muenster U; Frank K; Hutchins P; Williams J; Klumpp L; Wielockx K; Berben P; Augustijns P; Holm R; Hofmann M; Patel S; Beato S; Ojala K; Tomaszewska I; Bruel JL; Butler J
Mol Pharm; 2017 Dec; 14(12):4192-4201. PubMed ID: 28737403
[TBL] [Abstract][Full Text] [Related]
17. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
[TBL] [Abstract][Full Text] [Related]
18. Biorelevant in vitro assessment of dissolution and compatibility properties of a novel paediatric hydrocortisone drug product following exposure of the drug product to child-appropriate administration fluids.
Wollmer E; Neal G; Whitaker MJ; Margetson D; Klein S
Eur J Pharm Biopharm; 2018 Dec; 133():277-284. PubMed ID: 30385421
[TBL] [Abstract][Full Text] [Related]
19. Biorelevant Dissolution Models for a Weak Base To Facilitate Formulation Development and Overcome Reduced Bioavailability Caused by Hypochlordyria or Achlorhydria.
Kou D; Dwaraknath S; Fischer Y; Nguyen D; Kim M; Yiu H; Patel P; Ng T; Mao C; Durk M; Chinn L; Winter H; Wigman L; Yehl P
Mol Pharm; 2017 Oct; 14(10):3577-3587. PubMed ID: 28834434
[TBL] [Abstract][Full Text] [Related]
20. Application of the GastroDuo as an in Vitro Dissolution Tool To Simulate the Gastric Emptying of the Postprandial Stomach.
Schick P; Sager M; Wegner F; Wiedmann M; Schapperer E; Weitschies W; Koziolek M
Mol Pharm; 2019 Nov; 16(11):4651-4660. PubMed ID: 31593480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
